Literature DB >> 11772983

Small intestinal bacterial overgrowth, intestinal permeability, and non-alcoholic steatohepatitis.

S M Riordan, V M Duncombe, M C Thomas, A Nagree, T D Bolin, C J McIver, R Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11772983      PMCID： PMC1773090          DOI： 10.1136/gut.50.1.136-a

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

Review 1.  AGA technical review on the evaluation and management of chronic diarrhea.

Authors:  K D Fine; L R Schiller
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

2.  The lactulose breath hydrogen test and small intestinal bacterial overgrowth.

Authors:  S M Riordan; C J McIver; B M Walker; V M Duncombe; T D Bolin; M C Thomas
Journal:  Am J Gastroenterol       Date:  1996-09       Impact factor: 10.864

3.  Liver damage in human small intestinal bacterial overgrowth.

Authors:  S M Riordan; C J McIver; R Williams
Journal:  Am J Gastroenterol       Date:  1998-02       Impact factor: 10.864

4.  Detection of small intestine bacterial overgrowth by means of a 14C-D-xylose breath test.

Authors:  C E King; P P Toskes; J C Spivey; E Lorenz; S Welkos
Journal:  Gastroenterology       Date:  1979-07       Impact factor: 22.682

5.  Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy.

Authors:  E Husebye; V Skar; T Høverstad; T Iversen; K Melby
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

6.  Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

7.  Factors influencing the 1-g 14C-D-xylose breath test for bacterial overgrowth.

Authors:  S M Riordan; C J McIver; V M Duncombe; T D Bolin; M C Thomas
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

8.  Value of the 14C-D-xylose breath test in patients with intestinal bacterial overgrowth.

Authors:  A Schneider; B Novis; V Chen; G Leichtman
Journal:  Digestion       Date:  1985       Impact factor: 3.216

9.  Diagnosis of bacterial overgrowth of the small intestine. Comparison of the 14C-D-xylose breath test and jejunal cultures in 60 patients.

Authors:  J J Rumessen; E Gudmand-Høyer; E Bachmann; T Justesen
Journal:  Scand J Gastroenterol       Date:  1985-12       Impact factor: 2.423
  9 in total
  10 in total

1.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

2.  Increased orocecal transit time in patients with nonalcoholic fatty liver disease.

Authors:  Alejandro Soza; Arnoldo Riquelme; Robinson González; Manuel Alvarez; Rosa María Pérez-Ayuso; Juan Carlos Glasinovic; Marco Arrese
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

3.  Abnormal small intestinal permeability in patients with idiopathic malabsorption in tropics (tropical sprue) does not change even after successful treatment.

Authors:  Sunil Kumar; Uday C Ghoshal; Kamaiah Jayalakshmi; Raja Roy; Asha Misra; C L Khetrapal
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

4.  Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats.

Authors:  Xi Jin; Chao-Hui Yu; Guo-Cai Lv; You-Ming Li
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

5.  The effect of a probiotic on hepatic steatosis.

Authors:  Steven F Solga; Gillian Buckley; Jeanne M Clark; Alena Horska; Anna Mae Diehl
Journal:  J Clin Gastroenterol       Date:  2008 Nov-Dec       Impact factor: 3.062

6.  Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats.

Authors:  Wan-Chun Wu; Wei Zhao; Sheng Li
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 7.  Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.

Authors:  F Lirussi; E Mastropasqua; S Orando; R Orlando
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 8.  The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.

Authors:  Silvia M Ferolla; Geyza N A Armiliato; Cláudia A Couto; Teresa C A Ferrari
Journal:  Nutrients       Date:  2014-12-03       Impact factor: 5.717

9.  Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.

Authors:  Silvia M Ferolla; Cláudia A Couto; Luciana Costa-Silva; Geyza N A Armiliato; Cristiano A S Pereira; Flaviano S Martins; Maria de Lourdes A Ferrari; Eduardo G Vilela; Henrique O G Torres; Aloísio S Cunha; Teresa C A Ferrari
Journal:  Nutrients       Date:  2016-06-28       Impact factor: 5.717

10.  Plasma diamine oxidase level predicts 6-month readmission for patients with hepatitis B virus-related decompensated cirrhosis.

Authors:  Feng-Cai Li; Yu-Chen Fan; Yue-Kai Li; Kai Wang
Journal:  Virol J       Date:  2019-09-18       Impact factor: 4.099
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.